Biologix FZco, a company organized and existing under the laws of the United Arab Emirates, was incorporated in the Dubai Airport Free Zone in September 2002 as a regional supplier and promoter of Biotechnology products. Biologix FZco is a service provider to Pharmaceutical and Biotech companies and performs Named Patient Supply, market access, promotion and sales, detailing, logistics, registration, medical and disease awareness activities including Pharmacovigilance and Risk Management Plan, on behalf of its partners in the Middle East and North Africa (MENA) markets. Biologix main partners include: Acino, Amarin, Biogen, Cardiome,Celgene, Chiesi, Ipsen, Jazz Pharmaceuticals, Orexigen, Takeda and Shire. Biologix premises are being regularly audited by the Ministry of Health in the United Arab Emirates and by its Principals and business partners. Furthermore, the company has acquired the ISO 9001:2000 Certification. For the past 15 years, Biologix has been and continues to address the needs of patients in the MENA suffering from serious and critical conditions by ensuring a fast supply of innovative products of the highest quality.